These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 21088421)

  • 1. Adjuvant therapy in pancreatic cancer.
    Thomas A; Dajani K; Neoptolemos JP; Ghaneh P
    Dig Dis; 2010; 28(4-5):684-92. PubMed ID: 21088421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant therapy for pancreatic cancer.
    Sultana A; Cox T; Ghaneh P; Neoptolemos JP
    Recent Results Cancer Res; 2012; 196():65-88. PubMed ID: 23129367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant therapy in pancreatic cancer: a critical appraisal.
    Oettle H; Neuhaus P
    Drugs; 2007; 67(16):2293-310. PubMed ID: 17983252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant and adjuvant strategies for pancreatic cancer.
    Ghaneh P; Smith R; Tudor-Smith C; Raraty M; Neoptolemos JP
    Eur J Surg Oncol; 2008 Mar; 34(3):297-305. PubMed ID: 17936564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical overview: adjuvant therapy of gastrointestinal cancer.
    Macdonald JS
    Cancer Chemother Pharmacol; 2004 Sep; 54 Suppl 1():S4-11. PubMed ID: 15309508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systematic review and network meta-analysis of phase III randomised controlled trials for adjuvant therapy following resection of pancreatic ductal adenocarcinoma (PDAC).
    Kamarajah SK; Bundred JR; Alrawashdeh W; Manas D; White SA
    HPB (Oxford); 2020 May; 22(5):649-659. PubMed ID: 31894014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant therapy in pancreatic cancer: historical and current perspectives.
    Neoptolemos JP; Cunningham D; Friess H; Bassi C; Stocken DD; Tait DM; Dunn JA; Dervenis C; Lacaine F; Hickey H; Raraty MG; Ghaneh P; Büchler MW
    Ann Oncol; 2003 May; 14(5):675-92. PubMed ID: 12702520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Open-label, multicenter, randomized phase III trial of adjuvant chemoradiation plus interferon Alfa-2b versus fluorouracil and folinic acid for patients with resected pancreatic adenocarcinoma.
    Schmidt J; Abel U; Debus J; Harig S; Hoffmann K; Herrmann T; Bartsch D; Klein J; Mansmann U; Jäger D; Capussotti L; Kunz R; Büchler MW
    J Clin Oncol; 2012 Nov; 30(33):4077-83. PubMed ID: 23008325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strength of the evidence: adjuvant therapy for resected pancreatic cancer.
    Picozzi VJ; Pisters PW; Vickers SM; Strasberg SM
    J Gastrointest Surg; 2008 Apr; 12(4):657-61. PubMed ID: 18157582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results and patterns of failure in patients treated with adjuvant combined chemoradiation therapy for resected pancreatic adenocarcinoma.
    Hattangadi JA; Hong TS; Yeap BY; Mamon HJ
    Cancer; 2009 Aug; 115(16):3640-50. PubMed ID: 19514088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant 5-fluorouracil and folinic acid vs observation for pancreatic cancer: composite data from the ESPAC-1 and -3(v1) trials.
    Neoptolemos JP; Stocken DD; Tudur Smith C; Bassi C; Ghaneh P; Owen E; Moore M; Padbury R; Doi R; Smith D; Büchler MW
    Br J Cancer; 2009 Jan; 100(2):246-50. PubMed ID: 19127260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant therapy of pancreatic cancer: beyond gemcitabine. Highlights from the "2011 ASCO Gastrointestinal Cancers Symposium". San Francisco, CA, USA. January 20-22, 2011.
    Saif MW
    JOP; 2011 Mar; 12(2):106-9. PubMed ID: 21386631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress report. A randomized multicenter European study comparing adjuvant radiotherapy, 6-mo chemotherapy, and combination therapy vs no-adjuvant treatment in resectable pancreatic cancer (ESPAC-1).
    Neoptolemos JP; Baker P; Beger H; Link K; Pederzoli P; Bassi C; Dervenis C; Friess H; Büchler M
    Int J Pancreatol; 1997 Apr; 21(2):97-104. PubMed ID: 9209950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ESPAC-1 trial progress report: the European randomized adjuvant study comparing radiochemotherapy, 6 months chemotherapy and combination therapy versus observation in pancreatic cancer.
    Neoptolemos JP; Kerr DJ; Beger H; Link K; Pederzoli P; Bassi C; Dervenis C; Fernandez-Cruz L; Laçaine F; Friess H; Büchler M
    Digestion; 1997; 58(6):570-7. PubMed ID: 9438604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy for pancreatic cancer.
    Springfeld C; Jäger D; Büchler MW; Strobel O; Hackert T; Palmer DH; Neoptolemos JP
    Presse Med; 2019 Mar; 48(3 Pt 2):e159-e174. PubMed ID: 30879894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The case for adjuvant chemotherapy in pancreatic cancer.
    Ghaneh P; Sultana A; Shore S; Stocken D; Neoptolemos J
    Best Pract Res Clin Gastroenterol; 2006 Apr; 20(2):383-401. PubMed ID: 16549334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial.
    Neoptolemos JP; Dunn JA; Stocken DD; Almond J; Link K; Beger H; Bassi C; Falconi M; Pederzoli P; Dervenis C; Fernandez-Cruz L; Lacaine F; Pap A; Spooner D; Kerr DJ; Friess H; Büchler MW;
    Lancet; 2001 Nov; 358(9293):1576-85. PubMed ID: 11716884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical treatment of pancreatic cancer: the role of adjuvant and multimodal therapies.
    Kleeff J; Michalski CW; Friess H; Büchler MW
    Eur J Surg Oncol; 2007 Sep; 33(7):817-23. PubMed ID: 17331695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Adjuvant therapy of pancreatic carcinoma].
    Oettle H; Arnold D; Riess H
    Praxis (Bern 1994); 2000 Nov; 89(48):2017-25. PubMed ID: 11142141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical study of the month. Adjuvant radio-chemotherapy and chemotherapy following curative resection of pancreatic cancer: results of the randomized trial ESPAC-1].
    Polus M; Jerusalem G; Sautois B; Silvestre RM; Collette MY; Closon MT; Fillet G
    Rev Med Liege; 2002 Feb; 57(2):119-22. PubMed ID: 11942178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.